DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.

Bruge C, Bourg N, Pellier E, Miagoux Q, Benabides M, Grossi N, Hayat H, Jarrige M, Polveche H, Agostini V, Brureau A, Vassilopoulos S, Evangelista T, Fernández-Eulate G, Stojkovic T, Richard I, Nissan X

Open source

DOI
10.1172/jci.insight.200054
Published
2026 Mar 23
Container
JCI insight
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.200054,
  title = {DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.},
  author = {Bruge C and Bourg N and Pellier E and Miagoux Q and Benabides M and Grossi N and Hayat H and Jarrige M and Polveche H and Agostini V and Brureau A and Vassilopoulos S and Evangelista T and Fernández-Eulate G and Stojkovic T and Richard I and Nissan X},
  year = {2026},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.200054},
  url = {https://doi.org/10.1172/jci.insight.200054}
}

RIS

TY  - JOUR
TI  - DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.
AU  - Bruge C
AU  - Bourg N
AU  - Pellier E
AU  - Miagoux Q
AU  - Benabides M
AU  - Grossi N
AU  - Hayat H
AU  - Jarrige M
AU  - Polveche H
AU  - Agostini V
AU  - Brureau A
AU  - Vassilopoulos S
AU  - Evangelista T
AU  - Fernández-Eulate G
AU  - Stojkovic T
AU  - Richard I
AU  - Nissan X
PY  - 2026
JO  - JCI insight
DO  - 10.1172/jci.insight.200054
UR  - https://doi.org/10.1172/jci.insight.200054
ER  - 

APA

C, B., N, B., E, P., Q, M., M, B., N, G., H, H., M, J., H, P., V, A., A, B., S, V., T, E., G, F., T, S., I, R., & X, N. (2026). DAB2 in LGMD R2: a molecular link between disease progression and lipid dysregulation.. JCI insight. https://doi.org/10.1172/jci.insight.200054

Source records